Holen Sie sich die Stockscreener-App
1.62
1.22%
-0.02
Vorhandelsmarkt:
1.62
20 20 Biolabs Inc Aktie (AIDX) Neueste Nachrichten
20/20 BioLabs licenses kidney disease prediction technology from ROKIT Healthcare - MSN
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
20/20 BioLabs enters exclusive technology license, access agreement with Rokit - TipRanks
What's Going On With 20/20 Biolabs Stock? - Benzinga
20/20 Biolabs Faces Decline Amid Market Rut - timothysykes.com
20/20 BioLabs licenses kidney disease prediction technology - Investing.com
20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate Advanced CKD Prediction Technology into Its Longevity Test Program - The Manila Times
Kidney disease risk check joins 20/20 BioLabs longevity test - Stock Titan
What is the current Price Target and Forecast for 20/20 Biolabs Inc. (AIDX) - Zacks Investment Research
What date does 20/20 Biolabs Inc.'s (AIDX) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
AIDX Stock Price, News & Analysis - Stock Titan
Debt to equity ratio of 20/20 Biolabs, Inc. – NASDAQ:AIDX - TradingView
AIDX: 20/20 Biolabs Inc.Options Chain - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Total Long Term Debt (Quarterly) - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Return On Assets (TTM) - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Total Expenses (TTM) - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Price Book Value - Zacks Investment Research
Cash per share of 20/20 Biolabs, Inc. – NASDAQ:AIDX - TradingView
Michael A. Ross Net Worth (2026) - GuruFocus
Michael Saul Lebowitz Net Worth (2026) - GuruFocus
Jonathan M Cohen Net Worth (2026) - GuruFocus
Prasanth Reddy Net Worth (2026) - GuruFocus
Jiming Zhou Net Worth (2026) - GuruFocus
20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies - Sahm
20/20 Biolabs, Inc. Revenue Breakdown – NASDAQ:AIDX - TradingView
Analysts Offer Insights on Healthcare Companies: 20/20 Biolabs, Inc. (AIDX) and Biogen (BIIB) - The Globe and Mail
20/20 BioLabs provides update on protein biomarket technology for MCED - TipRanks
Jonathan Cohen Discloses Investment at 20/20 Biolabs with 16.8% Stake - TradingView
20/20 Biolabs (NASDAQ: AIDX) CEO holds 16.8% stake in company - Stock Titan
20/20 Biolabs (AIDX) CEO awarded 352,936-share stock option grant - Stock Titan
20/20 Biolabs Inc. (AIDX) Revenue (Quarterly) Yoy Growth - Zacks Investment Research
20/20 Biolabs (AIDX) 10K Form and SEC Filings 2026 - MarketBeat
20/20 Biolabs Inc. (AIDX) Free Cash Flow (TTM) - Zacks Investment Research
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
20/20 Biolabs Inc. (AIDX) Price To Cash Flow - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Net Income (Quarterly) - Zacks Investment Research
AIDX News Today | Why did 20/20 Biolabs stock go down today? - MarketBeat
20/20 Biolabs (AIDX) Stock Price, News & Analysis - MarketBeat
20/20 Biolabs Inc. (AIDX) Cash From Operations (TTM) - Zacks Investment Research
Number of employees of 20/20 Biolabs, Inc. – NASDAQ:AIDX - TradingView
20/20 Biolabs Inc. (AIDX) Cash From Financing (TTM) - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Dividend Yield (TTM) - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Shareholders Equity (Quarterly) - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Revenue (Quarterly) - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Profit Margin (Quarterly) - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Revenue (TTM) - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Total Assets (Quarterly) - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Ps Ratio (TTM) - Zacks Investment Research
20/20 Biolabs, Inc. Common Stock (AIDX) Competitors - Meyka
20/20 Biolabs, Inc. Common Stock (AIDX) AI-Powered Stock Analysis - Meyka
AIDX News Today: Stay Updated with the Latest 20/20 Biolabs, Inc. Common Stock News in Real Time - Meyka
Why Is 20/20 Biolabs, Inc. Common Stock (AIDX) Stock Up Today? - Meyka
20/20 Biolabs, Inc. Common Stock (AIDX) Fundamental Analysis - Meyka
AIDX : 20/20 Biolabs Inc. Key Company Details - Zacks Investment Research
Operating income of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView
Non-operating income (total) of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView
Diluted earnings per share (diluted EPS) of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView
Net income before discontinued operations of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView
AIDX Price History for 20/20 Biolabs Stock - Barchart.com
Non-controlling/minority interest of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView
Equity in earnings of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView
Taxes of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView
Operating expenses (excl. COGS) of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView
Diluted net income available to common stockholders of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView
After tax other income/expense of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView
1.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):